Hanson & Doremus Investment Management
Source: SEC Form 13F · as of Mar 2026Hanson & Doremus Investment Management holds 27 biotech & pharma companies tracked by BioSniper, totaling $35K in value as of Mar 2026 (SEC Form 13F).
Companies held
27
Total value held
$35K
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 58,928 | $7K |
| AMGNAMGEN INC | 11,185 | $4K |
| JNJJOHNSON & JOHNSON | 15,840 | $4K |
| ABBVAbbVie Inc. | 15,698 | $3K |
| LLYELI LILLY & Co | 3,665 | $3K |
| ABTABBOTT LABORATORIES | 25,393 | $3K |
| IQVIQVIA Holdings Inc. | 14,109 | $2K |
| MCKMcKesson Corporation | 1,984 | $2K |
| PFEPFIZER INC | 58,337 | $2K |
| AZNASTRAZENECA PLC | 6,009 | $1K |
| BMYBRISTOL MYERS SQUIBB CO | 19,527 | $1K |
| NVSNovartis AG | 4,528 | $692 |
| GILDGILEAD SCIENCES, INC. | 2,344 | $327 |
| ZTSZoetis Inc. | 2,126 | $251 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 554 | $247 |
| RDYDR REDDYS LABORATORIES LTD | 15,161 | $210 |
| NVONovo Nordisk A/S | 5,000 | $184 |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 601 | $163 |
| BIIBBIOGEN INC. | 525 | $96 |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 1,640 | $91 |
| PMPhilip Morris International Inc | 452 | $75 |
| GEHCGE HealthCare Technologies Inc. | 663 | $47 |
| ELVElevance Health Inc. | 127 | $37 |
| CORCencora Inc. | 77 | $24 |
| REGNREGENERON PHARMACEUTICALS, INC. | 16 | $12 |
| BAXBaxter International Inc. | 444 | $7 |
| VTRSViatris Inc | 94 | $1 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.